SILVERNAIL LAUREN P 4
4 · Harpoon Therapeutics, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
SILVERNAIL LAUREN P
Director
Transactions
- Award
Director Stock Option (right to buy)
2022-09-15+20,335→ 20,335 totalExercise: $1.62Exp: 2032-09-14→ Common Stock (20,335 underlying)
Footnotes (1)
- [F1]The stock option vests in three equal annual installments measured from the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.